Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 28;14(8):1565.
doi: 10.3390/pharmaceutics14081565.

Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis

Luigino Calzetta  1 , Marina Aiello  1 , Annalisa Frizzelli  1 , Beatrice Ludovica Ritondo  2 , Elena Pistocchini  2 , Paola Rogliani  2 , Alfredo Chetta  1
Affiliations
Review

Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis

Luigino Calzetta et al. Pharmaceutics. .

Abstract

Despite females being more often affected by asthma than males and the prevalence of COPD rising in females, conflicting evidence exists as to whether sex may modulate the correct inhaler technique. The aim of this study was to assess the impact of sex on the proper use of inhaler devices in asthma and COPD. A pairwise meta-analysis was performed on studies enrolling adult males and females with asthma or COPD and reporting data of patients making at least one error by inhaler device type (DPI, MDI, and SMI). The data of 6,571 patients with asthma or COPD were extracted from 12 studies. A moderate quality of evidence (GRADE +++) indicated that sex may influence the correct use of inhaler device in both asthma and COPD. The critical error rate was higher in females with asthma (OR 1.31, 95%CI 1.14−1.50) and COPD (OR 1.80, 95%CI 1.22−2.67) using DPI vs. males (p < 0.01). In addition, the use of SMI in COPD was associated with a greater rate of critical errors in females vs. males (OR 5.36, 95%CI 1.48−19.32; p < 0.05). No significant difference resulted for MDI. In conclusion, choosing the right inhaler device in agreement with sex may optimize the pharmacological treatment of asthma and COPD.

Keywords: COPD; asthma; inhaler device; inhaler technique; meta-analysis; sex.

PubMed Disclaimer

Conflict of interest statement

L.C. has participated as advisor in scientific meetings under the sponsorship of Boehringer Ingelheim and Novartis; received nonfinancial support from AstraZeneca; a research grant partially funded by Chiesi Farmaceutici, Boehringer Ingelheim, No-vartis, and Almirall; is or has been a consultant to ABC Farmaceutici, Edmond Phar-ma, Zambon, Verona Pharma, and Ockham Biotech; and his department was funded by Almirall, Boehringer Ingelheim, Chiesi Farmaceutici, Novartis, and Zambon. M.A. has no conflicts of interest to declare. A.F. has no conflicts of interest to declare. B.L.R. has no conflicts of interest to declare. E.P. has no conflicts of interest to declare. P.R. reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, personal fees from AstraZeneca, grants and personal fees from Chiesi Farmaceutici, grants and personal fees from Almirall, grants from Zambon, personal fees from Biofutura, personal fees from GlaxoSmithKline, personal fees from Menarini, personal fees from Mundipharma. A.C. received grants from Menarini and AstraZeneca, and personal fees from Chiesi Farmaceutici.

Figures

Figure 1
Figure 1
PRISMA 2020 flow diagram for the identification of the clinical studies included in the qualitative and quantitative syntheses. CENTRAL: Cochrane Central Register of Controlled Trials; PIF: peak inspiratory flow; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 2
Figure 2
Forest plots of the association between the frequency of making at least one overall error (A) [51,52,54,60] or one critical error (B) [53,56,59,61] in the use of inhaler devices in asthma. DPI: dry powder inhaler; MDI: metered-dose inhaler; OR: odds ratio; 95%CI: 95% confidence interval.
Figure 3
Figure 3
Forest plots of the association between the frequency of making at least one overall error (A) [31,54,57,58] or one critical error (B) [31,55] in the use of inhaler devices in COPD. DPI: dry powder inhaler; MDI: metered-dose inhaler; OR: odds ratio; SMI: soft mist inhaler; 95%CI: 95% confidence interval.
Figure 4
Figure 4
Assessment of the risk of bias via the Cochrane RoB 2 tool displayed by means of a traffic light plot of the risk of bias of the included randomized clinical study (A) [31], and weighted plot for the distribution of the overall risk of bias within each bias domain via the Cochrane RoB 2 tool (B) (n = 1 clinical study). Traffic light plot reports five risk of bias domains: D1, bias arising from the randomization process; D2, bias due to deviations from intended intervention; D3, bias due to missing outcome data; D4, bias in measurement of the outcome; D5, bias in selection of the reported result. Yellow circle indicates some concerns on the risk of bias, green circle represents low risk of bias, and blue circle indicates no information. RoB: risk of bias.
See this image and copyright information in PMC

References

    1. GINA 2021 GINA Main Report|Global Initiative for Asthma. [(accessed on 22 July 2021)]. Available online: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V....
    1. Asthma. [(accessed on 22 February 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/asthma.
    1. GOLD Global Strategy for Prevention, Diagnosis and Management of COPD: 2022 Report. 2022. [(accessed on 14 March 2022)]. Available online: https://goldcopd.org/2022-gold-reports-2/
    1. Roche N., Plaza V., Backer V., van der Palen J., Cerveri I., Gonzalez C., Safioti G., Scheepstra I., Patino O., Singh D. Asthma Control and COPD Symptom Burden in Patients Using Fixed-Dose Combination Inhalers (SPRINT Study) NPJ Prim. Care Respir. Med. 2020;30:1. doi: 10.1038/s41533-019-0159-1. - DOI - PMC - PubMed
    1. Melani A.S., Bonavia M., Cilenti V., Cinti C., Lodi M., Martucci P., Serra M., Scichilone N., Sestini P., Aliani M., et al. Inhaler Mishandling Remains Common in Real Life and Is Associated with Reduced Disease Control. Respir. Med. 2011;105:930–938. doi: 10.1016/j.rmed.2011.01.005. - DOI - PubMed

LinkOut - more resources